Generation Bio Announces 1-for-10 Reverse Stock Split
(NASDAQ:GBIO), CAMBRIDGE, Mass., July 18, 2025 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq: GBIO), a biotechnology company working to change what's possible for people living with T cell-driven autoimmune diseases, today announced that it will implement a 1-for-10 reverse stock split of the issued shares of the Company's common stock (“Reverse Stock Split”), effective at […]